Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow MARAVAI LIFESCIENCES HOLDINGS, INC.

Get SEC filing alerts via email and in your feed for MARAVAI LIFESCIENCES HOLDINGS, INC.

MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Maravai LifeSciences provides critical products and services for biopharmaceutical research, vaccine development, gene and cell therapies, and diagnostics. Its core segments include nucleic acid production—specializing in mRNA, oligonucleotides, and related reagents—and biologics safety testing, focusing on impurity detection and process validation. The company supports customers worldwide through proprietary technologies, high-quality manufacturing, and comprehensive analytical solutions throughout the drug development lifecycle.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from MARAVAI LIFESCIENCES HOLDINGS, INC.

1
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports 40.5% Revenue Growth to $65.8 Million in Q1 2026

Via official filing (AI summary) | 27 days ago | 0 comments

2
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports $185.7M Revenue and $230.8M Net Loss for 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports 39.7% Revenue Decline in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports 31.7% Revenue Decline and $69.8 Million Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports 27% Revenue Decline and $52.9 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports $259.6M Net Loss and 10.3% Revenue Decline for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
MARAVAI LIFESCIENCES HOLDINGS, INC. Maravai LifeSciences Reports Decline in Revenue and Significant Losses for Q3 and Nine Months of 2024

Via official filing (AI summary) | over 1 year ago | 0 comments